Deal Release | Advent International Corporation | Acquisition of controlling stake in RA Chem Pharma Ltd

The details of the deal are: 

Sector: Pharmaceuticals

Announcement Date: 30th July 2020

Name of the client: Advent International Corporation(C03266)

Acquirer Name and Description: Advent International Corporation | India 

AI Pharmed Consultancy India Private Limited is a special purpose vehicle controlled by private equity funds managed by Advent International Corporation. Advent International Corporation is a global private equity firm engaged in buy-outs and growth equity investments.

Target Name and Description: RA Chem Pharma Ltd

RA Chem is a leading API and formulations manufacturer, with various US FDA approved manufacturing units.

Deal description: Acquisition of a controlling stake in RA Chem Pharma Ltd from its promoter Micro Labs Ltd. 

Total consideration: Confidential

Team members: Aakash Choubey (Partner), Aashutosh Sampat (Partner), Ashutosh Sharma (Principal Associate) and Abir Sarkar (Senior Associate) with assistance from Associates Rhea Jha, Reshma Abraham, Nikunj Keyal and Aditi Sharma on due diligence.

Role of the firm: Acted as the legal counsel to Advent International Corporation.

Other legal advisors: AZB & Partners (Legal counsels to the Target)